Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.91 USD | +2.89% | -1.01% | -34.83% |
Apr. 24 | InnovAge Holding Corp. Launches PACE Center in Los Angeles | CI |
Mar. 13 | JPMorgan Adjusts Price Target on InnovAge to $6 From $7, Maintains Neutral Rating | MT |
Valuation
Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 2,888 | 593.6 | 1,017 | 531.4 | - | - |
Enterprise Value (EV) 1 | 2,764 | 484.5 | 917.1 | 545 | 538.1 | 507.2 |
P/E ratio | -59.2 x | -87.6 x | -25 x | -25.1 x | 133 x | 22.5 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 4.53 x | 0.85 x | 1.48 x | 0.7 x | 0.63 x | 0.55 x |
EV / Revenue | 4.33 x | 0.69 x | 1.33 x | 0.72 x | 0.64 x | 0.53 x |
EV / EBITDA | 32.4 x | 14.1 x | -727 x | 33.9 x | 14.7 x | 7.5 x |
EV / FCF | -110 x | -44.3 x | -294 x | -22.2 x | 154 x | 14.9 x |
FCF Yield | -0.91% | -2.26% | -0.34% | -4.5% | 0.65% | 6.7% |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 135,517 | 135,525 | 135,630 | 135,899 | - | - |
Reference price 2 | 21.31 | 4.380 | 7.500 | 3.910 | 3.910 | 3.910 |
Announcement Date | 9/21/21 | 9/13/22 | 9/12/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | 567.2 | 637.8 | 698.6 | 688.1 | 755.2 | 847 | 960.1 |
EBITDA 1 | - | 85.33 | 34.25 | -1.261 | 16.06 | 36.58 | 67.59 |
EBIT 1 | - | -12.34 | -4.406 | -49.4 | -19.97 | 11.2 | 34.37 |
Operating Margin | - | -1.93% | -0.63% | -7.18% | -2.64% | 1.32% | 3.58% |
Earnings before Tax (EBT) 1 | - | -34.97 | -7.237 | -50.79 | -23.67 | 4.526 | 31.63 |
Net income 1 | - | -43.99 | -6.521 | -40.67 | -21.74 | 1.566 | 20.96 |
Net margin | - | -6.9% | -0.93% | -5.91% | -2.88% | 0.18% | 2.18% |
EPS 2 | 0.1900 | -0.3600 | -0.0500 | -0.3000 | -0.1559 | 0.0294 | 0.1740 |
Free Cash Flow 1 | - | -25.09 | -10.94 | -3.118 | -24.5 | 3.5 | 34 |
FCF margin | - | -3.93% | -1.57% | -0.45% | -3.24% | 0.41% | 3.54% |
FCF Conversion (EBITDA) | - | - | - | - | - | 9.57% | 50.3% |
FCF Conversion (Net income) | - | - | - | - | - | 223.49% | 162.22% |
Dividend per Share 2 | - | - | - | - | - | - | - |
Announcement Date | 12/17/20 | 9/21/21 | 9/13/22 | 9/12/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 173.1 | 175.4 | 177.4 | 172.9 | 171.2 | 167.5 | 172.5 | 176.9 | 182.5 | 188.9 | 188.3 | 196 | 206.5 | 210.3 | 206 |
EBITDA 1 | 18.21 | 14.75 | 1.931 | -0.642 | -3.815 | -1.954 | 3.789 | 0.716 | 2.226 | 7.771 | 0.9591 | 5.166 | 7.594 | 8.004 | 7.6 |
EBIT 1 | 11.66 | 2.953 | -6.673 | -12.35 | -16.6 | -13.68 | -8.169 | -10.94 | -10.72 | -1.785 | -5.572 | -2.162 | -0.081 | 1.682 | - |
Operating Margin | 6.74% | 1.68% | -3.76% | -7.14% | -9.7% | -8.17% | -4.73% | -6.19% | -5.87% | -0.94% | -2.96% | -1.1% | -0.04% | 0.8% | - |
Earnings before Tax (EBT) 1 | 10.62 | 2.307 | -7.274 | -12.89 | -17.17 | -13.46 | -8.675 | -11.49 | -10.74 | -3.728 | -5.688 | -1.581 | 1.777 | 2.419 | - |
Net income 1 | 7.686 | 1.323 | -2.821 | -12.71 | -13.07 | -9.793 | -6.63 | -11.18 | -10.3 | -3.447 | -5 | -1 | - | - | - |
Net margin | 4.44% | 0.75% | -1.59% | -7.35% | -7.64% | -5.85% | -3.84% | -6.32% | -5.65% | -1.82% | -2.65% | -0.51% | - | - | - |
EPS 2 | 0.0600 | 0.0100 | -0.0200 | -0.0900 | -0.1000 | -0.0700 | -0.0500 | -0.0900 | -0.0800 | -0.0300 | -0.0350 | -0.0159 | -0.000200 | 0.007590 | 0.0100 |
Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/9/21 | 2/9/22 | 5/10/22 | 9/13/22 | 11/8/22 | 2/7/23 | 5/9/23 | 9/12/23 | 11/7/23 | 2/6/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 13.6 | 6.76 | - |
Net Cash position 1 | - | 124 | 109 | 100 | - | - | 24.1 |
Leverage (Debt/EBITDA) | - | - | - | - | 0.8493 x | 0.1849 x | - |
Free Cash Flow 1 | - | -25.1 | -10.9 | -3.12 | -24.5 | 3.5 | 34 |
ROE (net income / shareholders' equity) | - | -20.2% | 4.43% | -12.9% | -7.41% | 5.13% | 9.1% |
ROA (Net income/ Total Assets) | - | - | 2.72% | -7.24% | -3.89% | -0.5% | 1.93% |
Assets 1 | - | - | -239.9 | 561.5 | 558.2 | -315.7 | 1,086 |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | - | 17.5 | 38.2 | 23.4 | 14 | 23.5 | 12 |
Capex / Sales | - | 2.75% | 5.47% | 3.39% | 1.85% | 2.77% | 1.25% |
Announcement Date | 12/17/20 | 9/21/21 | 9/13/22 | 9/12/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.83% | 531M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+10.92% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-3.97% | 11.66B | |
-1.42% | 11.72B | |
-31.75% | 11.77B |
- Stock Market
- Equities
- INNV Stock
- Financials InnovAge Holding Corp.